| Source: |
| Type: |
| Myelosuppression — Suppression of bone-marrow hematopoietic activity resulting in reduced production of one or more blood-cell lineages. It commonly manifests as neutropenia, leukopenia, anemia, thrombocytopenia, or pancytopenia and is a frequent dose-limiting toxicity of cytotoxic chemotherapy and some targeted therapies. Typical modulation: ↑ myelosuppression is generally unfavorable and indicates greater hematologic toxicity. ↓ myelosuppression is favorable when evaluating treatment tolerability or protective interventions. Typical mechanistic relationship: Bone-marrow progenitor-cell injury or suppression → hematopoiesis ↓ → neutrophils / leukocytes / erythrocytes / platelets ↓ → infection, fatigue, bleeding, and treatment-delay risk ↑. |
| 9036- | SP, | The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors |
| - | Trial, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1914 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid